pink ceramic hip component — CoorsTek Bioceramics has prevailed again in its long-running legal battle with CeramTec GmbH over the color pink as a trademark for ceramic hip components. The German Federal Patent Court (GFPC) upheld the cancellation of CeramTec’s German trademark, concluding that the application was filed in bad faith to prolong an expiring patent monopoly and prevent competitors from entering the market.
Court Finds Bad Faith in Trademark Application
The GFPC’s decision centers on the timing and intent behind CeramTec’s trademark filing. According to the ruling, the application was not a legitimate effort to protect a brand but rather an attempt to extend the commercial exclusivity that had been granted through a patent nearing expiration. By seeking trademark rights over the color pink for ceramic hip components, CeramTec aimed to block rivals from using a visual characteristic that had become associated with the product category.
The court’s finding of bad faith is significant because it reinforces the principle that trademark protection cannot be used as a substitute for expired patent rights. The ruling upholds the cancellation of the trademark in Germany, removing a barrier that CoorsTek Bioceramics said had limited its ability to market its ceramic hip replacement components in the country.
CoorsTek Bioceramics Expands Market Access
For CoorsTek Bioceramics, the German decision is the latest in a series of favorable outcomes. The company stated that the ruling strengthens its position to offer ceramic hip components, including its Permallon orthopaedic ceramics, to customers in Germany. The decision follows similar victories in France and the United States, where courts have also addressed the disputed trademark rights.
CoorsTek Bioceramics is a wholly owned subsidiary of CoorsTek, Inc., and specializes in technical ceramic implant components for the medical device industry. The company has focused on ceramic bearing surfaces for total joint arthroplasty and has sold more than six million components for clinical use since 2005. Its products also appear in implant devices for neurological, cardiological, spinal, and radiation applications.
The company said the court wins, combined with regulatory clearances from original equipment manufacturers, are helping to build a more competitive supply chain for orthopaedic ceramics. That supply chain serves medical device makers that rely on ceramic components for hip replacements and other joint reconstruction procedures.
CeramTec to Appeal as Dispute Continues
CeramTec has appealed the GFPC’s decision, meaning the legal fight over the pink trademark is not yet final. The appeal will likely focus on the court’s bad faith finding and the scope of trademark protection for colors in the medical device field. For now, the cancellation remains in effect in Germany, and CoorsTek Bioceramics can continue to market its products while the appeal proceeds.
The dispute highlights a broader question in intellectual property law: how far companies can go to protect product appearances once patent rights expire. The GFPC’s ruling suggests that using trademark law to maintain a monopoly position can be deemed an abuse of the trademark system. CoorsTek Bioceramics has framed the outcome as a win for competition and for patients who may benefit from a wider range of ceramic hip component suppliers.
CoorsTek, founded in 1910 and still owned by the Coors family, manufactures technical ceramics for medical, semiconductor, aerospace, energy, and other industries. The parent company holds more than 400 proprietary material formulations and provides vertically integrated systems and process capabilities. Its bioceramics subsidiary continues to emphasize ceramic bearing surfaces for total joint arthroplasty as a core focus.
With the German ruling upheld, CoorsTek Bioceramics is pressing its advantage in Europe while CeramTec pursues its appeal. The outcome of that appeal could further clarify the boundaries of trademark protection for color in the orthopaedic ceramics market.